Antiphospholipid syndrome

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


Antiphospholipid antibodies (aPL) are autoantibodies directed against negatively charged phospholipid/plasma proteins. The most common plasma protein target is beta 2 glycoprotein I. The three most im-portant antiphospholipid antibodies are the lupus anti-coagulant, anticardiolipin, and anti-beta 2 glycoprotein I. Antiphospholipid syndrome (APS) is one of the most common acquired causes of hypercoagulability. Fifty percent of APS patients have systemic lupus erythe-matosus (SLE). APS presents in two major ways: thrombosis (venous or arterial) and pregnancy loss. Thrombocytopenia, present in about 20% of cases, can be an important clue.

Original languageEnglish (US)
Title of host publicationPrimer on the Rheumatic Diseases
Subtitle of host publicationThirteenth Edition
PublisherSpringer New York
Number of pages4
ISBN (Print)9780387356648
StatePublished - Dec 1 2008

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this